MYRIAD GENETICS, INC. Increase (Decrease) in Restricted Cash
MYRIAD GENETICS, INC. (MYGN) reported Increase (Decrease) in Restricted Cash of $21.60 million for the 6-month period ending 2014-12-31, per its 10-Q filed 2016-02-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2016-02-03
- MYRIAD GENETICS, INC. increase (decrease) in restricted cash for the quarter ending 2014-12-31 was -$1.10M.
- MYRIAD GENETICS, INC. increase (decrease) in restricted cash for the quarter ending 2014-09-30 was $22.70M.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 3 month as first filed | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 6 month as first filed |
|---|---|---|---|---|
| 2014-12-31 | -$1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-03 | $21.60M 10-Q · filed 2016-02-03 | $21.60M 10-Q · filed 2015-02-04 | |
| 2014-09-30 | $22.70M 10-Q · filed 2015-11-04 | $22.67M 10-Q · filed 2014-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |